MENU
+Compare
BHC
Stock ticker: NYSE
AS OF
Feb 21 closing price
Price
$7.31
Change
+$0.13 (+1.81%)
Capitalization
3.86B

BHC Bausch Health Companies Forecast, Technical & Fundamental Analysis

a manufacturer of pharmaceutical products

BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BHC with price predictions
Feb 20, 2025

BHC in +12.89% Uptrend, advancing for three consecutive days on February 20, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where BHC advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where BHC's RSI Indicator exited the oversold zone, of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 68 cases where BHC's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BHC just turned positive on February 20, 2025. Looking at past instances where BHC's MACD turned positive, the stock continued to rise in of 46 cases over the following month. The odds of a continued upward trend are .

BHC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 29, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BHC as a result. In of 79 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BHC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for BHC entered a downward trend on February 18, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.000) is normal, around the industry mean (59.993). P/E Ratio (13.387) is within average values for comparable stocks, (90.174). BHC's Projected Growth (PEG Ratio) (0.011) is slightly lower than the industry average of (2.987). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (0.433) is also within normal values, averaging (19.928).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. BHC’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BHC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
BHC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BHC is expected to report earnings to rise 228.36% to 82 cents per share on May 01

Bausch Health Companies BHC Stock Earnings Reports
Q1'25
Est.
$0.82
Q4'24
Beat
by $0.02
Q3'24
Missed
by $1.26
Q2'24
Beat
by $0.19
Q1'24
Missed
by $0.86
The last earnings report on February 19 showed earnings per share of 25 cents, beating the estimate of 23 cents. With 3.00M shares outstanding, the current market capitalization sits at 3.86B.
A.I.Advisor
published Dividends

BHC paid dividends on December 22, 2010

Bausch Health Companies BHC Stock Dividends
А quarterly dividend of $1.00 per share was paid with a record date of December 22, 2010, and an ex-dividend date of November 10, 2010. Read more...
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
2150 Saint Elzear Boulvard West
Phone
+1 514 744-6792
Employees
20270
Web
https://www.bauschhealth.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AFMBX35.76N/A
N/A
American Funds American Balanced F3
FERCX42.37N/A
N/A
Fidelity Advisor Emerging Asia C
ICISX17.23N/A
N/A
VY® Columbia Small Cap Value II I
BDSKX19.05N/A
N/A
BlackRock Advantage Small Cap Core K
BMSRX14.55N/A
N/A
MFS Blended Research Mid Cap Eq R1

BHC and Stocks

Correlation & Price change

A.I.dvisor tells us that BHC and HLN have been poorly correlated (+25% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BHC and HLN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BHC
1D Price
Change %
BHC100%
+10.29%
HLN - BHC
25%
Poorly correlated
-0.80%
SUPN - BHC
24%
Poorly correlated
+3.19%
DVAX - BHC
23%
Poorly correlated
+1.83%
SNDL - BHC
23%
Poorly correlated
-0.56%
AMRX - BHC
23%
Poorly correlated
+0.25%
More